7LGD
HLA-B*07:02 in complex with SARS-CoV-2 nucleocapsid peptide N105-113
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | AUSTRALIAN SYNCHROTRON BEAMLINE MX2 |
| Synchrotron site | Australian Synchrotron |
| Beamline | MX2 |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2020-07-06 |
| Detector | DECTRIS EIGER X 16M |
| Wavelength(s) | 0.987 |
| Spacegroup name | P 21 21 21 |
| Unit cell lengths | 64.454, 107.176, 174.190 |
| Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
| Resolution | 43.550 - 2.880 |
| R-factor | 0.2091 |
| Rwork | 0.206 |
| R-free | 0.26920 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | 5wmn |
| RMSD bond length | 0.009 |
| RMSD bond angle | 1.038 |
| Data reduction software | XDS |
| Data scaling software | Aimless (0.5.1) |
| Phasing software | PHASER |
| Refinement software | BUSTER |
Data quality characteristics
| Overall | Inner shell | Outer shell | |
| Low resolution limit [Å] | 46.650 | 46.650 | 3.040 |
| High resolution limit [Å] | 2.880 | 9.110 | 2.880 |
| Rmerge | 0.195 | 0.066 | 1.262 |
| Total number of observations | 191654 | 6180 | 26453 |
| Number of reflections | 28141 | 1005 | 4027 |
| <I/σ(I)> | 8 | 18.3 | 1.6 |
| Completeness [%] | 100.0 | 99.4 | 100 |
| Redundancy | 6.8 | 6.1 | 6.6 |
| CC(1/2) | 0.898 | 0.994 | 0.578 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | VAPOR DIFFUSION, HANGING DROP | 7.5 | 277 | 2M Ammonium Sulfate, 0.1M HEPES pH 7.5 |






